Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Er-shun Liang"'
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-11 (2022)
Abstract Rationale Genetic studies have proved the involvement of Tuberous sclerosis complex subunit 2 (Tsc2) in aortic aneurysm. However, the exact role of macrophage Tsc2 in the vascular system remains unclear. Here, we examined the potential funct
Externí odkaz:
https://doaj.org/article/1352c3e7591f41f0be57e858a80c51bc
Autor:
Qing-hua Lu, Ming-Xiang Zhang, Zhao-yang Wang, Ying Wang, Xue Liu, Bin Liu, Wen Qiao, Peng Li, Er-shun Liang, Fei Xie
Publikováno v:
Cell Death & Disease. 11
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Xi Zhang, De‑Shan Liu, Yan Jin, Lu‑Ning Ning, Min Ma, Er‑Shun Liang, Chang Ling Li, Fang Zhang, Wei Gao, Zhong‑Kuan Lyu, Ming‑Xiang Zhang, Yu‑Zhao Liu
Publikováno v:
Molecular Medicine Reports
Paeonol (Pae) is an herbal extract that has attracted extensive attention for its anti‑cancer effects demonstrated by a number of studies, which have predominantly demonstrated inhibition of cell proliferation and induction of apoptosis. The influe
Autor:
Qing-hua Lu, Wen Qiao, Xue Liu, Ying Wang, Ming-Xiang Zhang, Peng Li, Fei Xie, Zhao-yang Wang, Bin Liu, Er-shun Liang
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 1, Pp 1-13 (2020)
Cell Death and Disease, Vol 11, Iss 1, Pp 1-13 (2020)
Accelerated atherosclerotic calcification is responsible for plaque burden, especially in diabetes. The regulatory mechanism for atherosclerotic calcification in diabetes is poorly characterized. Here we show that deletion of PARP-1, a main enzyme in
Publikováno v:
Biochemical and Biophysical Research Communications. 479:109-115
Therapeutic management of diabetic myocardial fibrosis remains an unsolved clinical problem. Pin1, a peptidyl–prolyl isomerase, impacts diverse cellular processes and plays a pivotal role in regulating cardiac pathophysiology. Here we investigate t
Autor:
Ming-Xiang Zhang, Xiuhui Song, Er-shun Liang, Xue Liu, Zhanhui Du, Jianjun Lu, Yun Zhang, Xiaoqiong Liu, Yuxia Zhao, Xueying Chen
Publikováno v:
Oncotarget
// Xue Liu 1, 2 , Xiuhui Song 3 , Jianjun Lu 4 , Xueying Chen 1 , Ershun Liang 1 , Xiaoqiong Liu 5 , Mingxiang Zhang 1 , Yun Zhang 1 , Zhanhui Du 1 , Yuxia Zhao 2 1 The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Minist
Autor:
Wen-qian Dong, Hong-liang Tian, Wei Zhang, Yu-gang Yan, Ming-Xiang Zhang, Ruijuan Lv, Xue Liu, Peng Li, Er-shun Liang, Xueying Chen, Qing-hua Lu
Publikováno v:
Oncotarget
Cardiac fibrosis is an important pathological process of diabetic cardiomyopathy, the underlying mechanism remains elusive. This study sought to identify whether inhibition of Myocyte enhancer factor 2A (MEF2A) alleviates cardiac fibrosis by partiall
Autor:
Wen-qian Dong, Yu-gang Yan, Er-shun Liang, Ming-Xiang Zhang, Guoliang Liu, Yun Zhang, Wei Zhang, Xueying Chen, Jia-ning Zhang
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 69:52-61
Myocyte enhancer factor 2A (MEF2A) functions in muscle-specific and/or growth factor-related transcription and is involved in cell growth, survival, and apoptosis. To evaluate the role of this transcription factor in cardiac fibroblasts (CFs) in diab
Autor:
Fan Zhang, Ming-Xiang Zhang, Yang Ma, Weidong Qin, Jian-ning Zhang, Wen-wu Bai, Er-shun Liang, Fan Jiang, Mei Yin, Xiaomei Chen, Hao Wang
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 72(5)
Abdominal aortic aneurysm (AAA) is a common vascular degenerative disease. PARP-1 (poly[ADP-ribose] polymerase 1) is a nuclear enzyme, which plays a critical role in vascular diseases. We hypothesized that PARP-1 inhibition might have protective effe
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2018 (2018)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Andrographolide (Andro), a major bioactive component obtained from Andrographis paniculata Nees, has exerted wide antioxidant as well as cytoprotective properties. However, whether Andro treatment could retard the progress of diabetic cardiomyopathy